Terumo Interventional Systems today announced the completion of the first procedure in the U.S. using its OpusWave dual-sensor imaging system. The procedure, performed by Dr. Annapoorna S. Kini, took place on June 15 at Mount Sinai Fuster Heart Hospital in New York. Somerset, New Jersey-based Terumo Interventional says it marks a "significant … [Read more...] about Terumo reports first procedure using dual-sensor imaging system in US
Artivion earns FDA nod for aortic arch prosthesis device
Artivion (NYSE:AORT) announced today that it received FDA premarket approval (PMA) for its AMDS Hybrid Prosthesis device. The approval covers acute Debakey Type 1 aortic dissections with either clinical or radiographic malperfusion. Atlanta-based Artivion estimates that this population comprises approximately 60% of all Debakey Type 1 aortic … [Read more...] about Artivion earns FDA nod for aortic arch prosthesis device
Johnson & Johnson begins carotid IVL study enrollment
Johnson & Johnson (NYSE:JNJ) today announced the initiation of its SKYWARD clinical program for a new Shockwave IVL system. The SKYWARD FDA investigational device exemption (IDE) study evaluates the novel SkyRunner carotid intravascular lithotripsy (IVL) system for the treatment of calcified carotid arteries prior to stenting. SkyRunner, … [Read more...] about Johnson & Johnson begins carotid IVL study enrollment
Johnson & Johnson launches ThermoCool SmartTouch ablation tech in Europe
Johnson & Johnson (NYSE:JNJ) announced today that it launched its dual-energy ThermoCool SmartTouch platform in Europe. The launch expands access in the region to dual-energy catheter ablation for personalized care across workflows, anatomies and procedural strategies. J&J's ThermoCool SmartTouch platform combines the ThermoCool … [Read more...] about Johnson & Johnson launches ThermoCool SmartTouch ablation tech in Europe
Corvention launches KardiaPSI balloon catheter in US with first cases
Corvention announced today that it completed the first case in the U.S. with its proprietary KardiaPSI balloon catheter. The procedure, performed by Dr. Alan Zajarias in St. Louis, marked the official start of a limited rollout for the balloon catheter. Flagstaff, Arizona-based Corvention won FDA clearance for the device in balloon aortic … [Read more...] about Corvention launches KardiaPSI balloon catheter in US with first cases
Teleflex begins enrollment in resorbable magnesium scaffold study
Teleflex (NYSE:TFX) announced today that it began enrollment in the BIOMAG-III study of its Freesolve resorbable magnesium scaffold (RMS). Freesolve came to Teleflex through its 2025 acquisition of the Biotronik Vascular Interventions business. It features the BIOmag magnesium alloy and Orsiro drug-eluting stent coating technology. The company … [Read more...] about Teleflex begins enrollment in resorbable magnesium scaffold study
CereVasc completes enrollment in eShunt trial
CereVasc announced today that it completed patient enrollment in the STRIDE pivotal trial evaluating its investigational eShunt system. Boston-based CereVasc said it completed enrollment at 32 clinical sites. Now, STRIDE continues to progress through remaining treatment and follow-up activities for consented patients. The company said it is on … [Read more...] about CereVasc completes enrollment in eShunt trial
Medtronic brings PulseSelect pulsed field ablation tech to India
Medtronic (NYSE:MDT) announced the launch of its PulseSelect pulsed field ablation (PFA) platform in India. PulseSelect uses non-thermal energy to deliver cardiac ablation to treat AFib. The energy delivers pulmonary vein isolation while reducing the risk of damage to surrounding structures. Medtronic's system features nine electrodes on its … [Read more...] about Medtronic brings PulseSelect pulsed field ablation tech to India
Penumbra earns CE mark for Thunderbolt thrombectomy system
Penumbra (NYSE:PEN) announced today that it received CE mark approval for its Thunderbolt thrombectomy system for stroke. European approval for the computer-assisted vacuum thrombectomy (CAVT) technology comes just days after FDA clearance. Thunderbolt expands the company’s computer-assisted vacuum thrombectomy (CAVT) portfolio. It aims to … [Read more...] about Penumbra earns CE mark for Thunderbolt thrombectomy system
Medtronic completes acquisition of Scientia Vascular
Medtronic (NYSE:MDT) announced today that it completed its previously announced acquisition of Scientia Vascular for $550 million. In March, the medtech giant said it struck a deal to acquire Salt Lake City, Utah–based Scientia, which develops access products for treating complex neurovascular conditions. With the acquisition, Medtronic … [Read more...] about Medtronic completes acquisition of Scientia Vascular
